From Sudbury, Massachusetts, USA:
I've had gestational diabetes based on home blood glucose monitoring since the early weeks of pregnancy. Now, at 28 weeks, my fasting blood sugars have climbed over the limit as stated by the high-risk team (100 mg/dl [5.6 mmol/L]), and my two- hour post-prandials are over the limits, too (140 mg/dl [7.8 mmol/L]). I can tell by home monitoring that the gestational diabetes is getting to be impossible to control with diet alone.
If I took another GTT (I 'passed' the last one, but have been monitoring any way), would it tell the doctors how much insulin I should take? Can the insulin dosage be determined from my home blood glucose monitoring logs? I'd rather not take the GTT again if it's not going to help in the development of an insulin treatment plan.
How is insulin dosage to be determined? In short, can it be determined without another (torturous) GTT?
It is not necessary to repeat the glucose tolerance test. If your blood sugars are not being controlled by diet alone, then insulin will be needed. Dosing is initially based on body weight.
One thing you may want to bring up with you physician is the use of glyburide (an oral hypoglycemic agent). There is a recent report in the New England Journal of Medicine (Oct. 19, 2000) about the use of this drug in pregnancy. It appears safe and might be a reasonable alternative.
Original posting 26 Dec 2000
Posted to Gestational Diabetes
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:09:18
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.